2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies

Faculty of Pharmacy

Assiut University

2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies

Research Authors
Wesam S Qayed, Mostafa A. Hassan, Halil Şenol, Parham Taslimi, Tarek Aboul-Fadl
Research Date
Research Department
Department of Medicinal Chemistry
Research Journal
RSC Medicinal Chemistry
Research Publisher
Royal Society of Chemistry
Research Rank
Q1
Research Vol
16
Research Year
2025
Research Member
Tarek Aboul-Fadl Mohammad Hassan
Wesam Saber Abdel-Aal Qayed
Mostafa Ahmed Hassan Mohamed
Research_Pages
In press